A hotly debated lung cancer drug cut the risk of death by 34% in a late-stage trial in China ⊖⊖ found 2026 › May › 31 (Sun) @ 13:10 UTC a story from CNBC ⚠️ › World News China ■■■ Akeso ■■ Summit Therapeutics ■■ preview sentiment